Sign In
Buy SYK
$335.96
-5.24 (-1.54%)
At Close: Aug 04, 2026
Stryker's (SYK) Inks Deal to Aid Its Pain Management Portfolio
12:00pm, Friday, 23'rd Aug 2024
Stryker (SYK) is set to acquire Vertos Medical to expand its interventional pain management portfolio.
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
08:00am, Thursday, 22'nd Aug 2024
Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately he
Stryker to participate in the 2024 Wells Fargo Healthcare Conference
04:00pm, Monday, 19'th Aug 2024
Portage, Michigan, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, at the Encore Boston Harbor.
Stryker (SYK) to Acquire care.ai to Boost AI-Driven Healthcare
12:31pm, Tuesday, 13'th Aug 2024
Stryker's (SYK) acquisition of care.ai is set to enhance its healthcare IT offerings with AI-assisted virtual care workflows and smart room technology.
Stryker's (SYK) Pangea System to Enhance Plating Solutions
01:17pm, Thursday, 08'th Aug 2024
Stryker (SYK) announces the launch of its Pangea Plating System, which is likely to provide solutions for internal fixation and stabilization of bone fractures.
Stryker declares an $0.80 per share quarterly dividend
08:00am, Wednesday, 07'th Aug 2024
Portage, Michigan, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable October 31, 2024 to sharehold
Medical Technology Stock Benefits from Rising Acute Care Demand
07:15am, Wednesday, 07'th Aug 2024
Medical and surgical products manufacturer Stryker Co. NYSE: SYK is a beneficiary of the acute care boom occurring in the healthcare industry. Acute care is considered short-term intensive hospital-ba
Stryker (SYK) Completes MOLLI's Acquisition to Boost Business
02:05pm, Tuesday, 06'th Aug 2024
Stryker (SYK) completes of the acquisition of MOLLI, a privately held company, to strengthen its commitment to advancing surgical solutions in breast cancer care.
Stryker: Wait For A Better Entry Point Post-Q2 Results
04:09am, Tuesday, 06'th Aug 2024
Stryker is a global medical products and devices company that has global operations in over 75 countries. Historically, the company has been a compounder, generating high returns on capital and has pu
Compared to Estimates, Stryker (SYK) Q2 Earnings: A Look at Key Metrics
04:00pm, Wednesday, 31'st Jul 2024
While the top- and bottom-line numbers for Stryker (SYK) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
Stryker's (SYK) Q2 Earnings Beat Estimates, Guidance Raised
12:15pm, Wednesday, 31'st Jul 2024
Stryker (SYK) beats second-quarter earnings estimates, driven by robust sales growth and innovative launches like the LIFEPAK 35 and Spine Guidance 5. The company raises 2024 guidance.
Stryker CEO on earnings: We had a record quarter on robot installations
11:55am, Wednesday, 31'st Jul 2024
Kevin Lobo, Stryker CEO, joins 'Money Movers' to discuss the company's second quarter earnings as it saw strong demand for surgical procedures and new products.
Are Medical Stocks Lagging Stryker (SYK) This Year?
10:40am, Wednesday, 31'st Jul 2024
Here is how Stryker (SYK) and Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) have performed compared to their sector so far this year.
Stryker completes acquisition of MOLLI Surgical
08:45am, Wednesday, 31'st Jul 2024
SAN JOSE, California, USA, July 31, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of MOLLI Surgical Inc., a pr
Stryker Corporation (SYK) Q2 2024 Earnings Call Transcript
08:59pm, Tuesday, 30'th Jul 2024
Stryker Corporation (NYSE:SYK ) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and
